{"id":50890,"date":"2025-11-26T09:09:07","date_gmt":"2025-11-26T09:09:07","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/50890\/"},"modified":"2025-11-26T09:09:07","modified_gmt":"2025-11-26T09:09:07","slug":"usa-valitsus-peab-konelusi-15-ravimi-hinna-alandamise-ule-valismaa","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/50890\/","title":{"rendered":"USA valitsus peab k\u00f5nelusi 15 ravimi hinna alandamise \u00fcle | V\u00e4lismaa"},"content":{"rendered":"<p>USA valitsus peab riikliku tervishoiukindlustuss\u00fcsteemi Medicare raames l\u00e4bir\u00e4\u00e4kimisi 15 ravimi hinna langetamise \u00fcle. K\u00f5neluste raames \u00fcritab USA langetada ka kaalulangetus- ja diabeediravimi Ozempic hinda.<\/p>\n<p>Medicare pakub peamiselt eakatele tervisekindlustust, see aitab katta ka teatud ravimite kulusid. USA-s on retseptiravimid kalleimad maailmas ja paljud inimesed peavad suure osa kuludest omast taskust katma.<\/p>\n<p>Uued hinnad peaksid j\u00f5ustuma 2027. aastal ning hinnanguliselt peaks siis\u00a0 Medicare s\u00e4\u00e4stma 12 miljardit dollarit. See v\u00f5ib m\u00f5nede inimeste jaoks v\u00e4hendada omaosalustasu, kuid teised ei pruugi otsest kokkuhoidu n\u00e4ha, sest nende igakuised omaosalustasud on fikseeritud, vahendas <a href=\"https:\/\/www.wsj.com\/health\/pharma\/u-s-negotiates-lower-prices-for-ozempic-and-14-other-drugs-c410e72c?mod=hp_lead_pos5\" target=\"_blank\" rel=\"noopener nofollow\">The Wall Street Journal<\/a>.<\/p>\n<p>Lisaks Ozempicule v\u00f5ivad odavamaks muutuda ka mitmed astma- ja v\u00e4hiravimid. Hinnalangetus kehtiks aga ainult Medicare&#8217;i raames ega h\u00f5lmaks era\u00f5iguslikke tervisekindlustusprogramme.<\/p>\n<p>Medicare kulutab samas retseptiravimitele ligikaudu 150 miljardit dollarit aastas ning hindade langus v\u00e4hendaks ravimihiiglaste rahavoogu.\u00a0<\/p>\n<p>K\u00f5ige rohkem on t\u00e4helepanu\u00a0 p\u00e4lvinud v\u00f5imalik Ozempicu hinnalangus. Selle \u00fche kuu varu maksis 2024. aastal USA-s ligi 1000 dollarit kuus. Viimasel ajal on Novo Nordisk siiski oma kaalulangetusravimite hindu langetanud. Medicare&#8217;i uue kokkuleppe raames oleks selliste kaalulangetusravimite hind aga 274 dollarit.<\/p>\n<p>Uus kokkulepe oleks juba teine selline allahindluste voor. Eelmine administratsioon teatas m\u00f6\u00f6dunud aastal ajaloolisest kokkuleppest alandada 10 peamiselt eakatele vajaliku ravimi hinda. Sellised kokkulepped on v\u00f5imude jaoks oluline v\u00f5it, sest resoneerub paljude ameeriklaste murega elukalliduse p\u00e4rast. V\u00f5imud kavatsevad j\u00e4rgmisel aastal peetavateks l\u00e4bir\u00e4\u00e4kimisteks valida v\u00e4lja veel 15 ravimit.<\/p>\n","protected":false},"excerpt":{"rendered":"USA valitsus peab riikliku tervishoiukindlustuss\u00fcsteemi Medicare raames l\u00e4bir\u00e4\u00e4kimisi 15 ravimi hinna langetamise \u00fcle. K\u00f5neluste raames \u00fcritab USA langetada&hellip;\n","protected":false},"author":2,"featured_media":50891,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[131,130,37,33,35,34,36,25825,3401,25824,325],"class_list":{"0":"post-50890","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ari","8":"tag-ari","9":"tag-business","10":"tag-ee","11":"tag-eesti","12":"tag-eesti-keel","13":"tag-estonia","14":"tag-estonian","15":"tag-medicare","16":"tag-ozempic","17":"tag-ravimitoostus","18":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115615220653183159","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/50890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=50890"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/50890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/50891"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=50890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=50890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=50890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}